0910-AB28 200410 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 16 21 CFR 1270 21 CFR 1271 42 USC 216 42 USC 243 42 USC 263a 42 USC 264 42 USC 271 Yes NPRM 01/08/2001 66 FR 1508 NPRM Comment Period End 05/08/2001 Final Action 12/00/2004 Yes Businesses State No NA Not Collected Paula McKeever S. 0910 Food and Drug Administration FDA 301 827-1520 301 443-9718 paula.mckeever@fda.hhs.gov Suite 200N (HFM-17), Office of the Commissioner, Office of Critical Path Programs, 5600 Fishers Lane, Room 14B-45, Rockville MD 20857-0001